Envision Healthcare Reports Second Quarter Adjusted EBITDA of $162.8 Million, up 21% on Strong Revenue Growth and Adjusted EPS Increases by 32%

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. APGE
5. MU
6. GOOGL
7. DFTX
8. KR
9. MSTR
10. HOOD

Go back to Envision Healthcare Reports Second Quarter Adjusted EBITDA of $162.8 Million, up 21% on Strong Revenue Growth and Adjusted EPS Increases by 32%

Piper Jaffray Raises Price Target on Envision Healthcare (EVHC) Following 2Q EPS Beat

July 31, 2015 10:41 AM EDT

Piper Jaffray reiterated an Overweight rating on Envision Healthcare (NYSE: EVHC), and raised the price target to $45.00 (from $42.00), following 2Q results. EPS of $0.37 was $0.02 higher than consensus of $0.35.Revenue increased 25.9% y/y to $1,354M, which was $50M higher than consensus of $1,304M.... More

Envision Healthcare (EVHC) Tops Q2 EPS by 2c; Will Acquire Rural/Metro in $600M Deal

July 30, 2015 4:52 PM EDT

Envision Healthcare (NYSE: EVHC) reported Q2 EPS of $0.37, $0.02 better than the analyst estimate of $0.35. Revenue for the quarter came in at $1.35 billion versus the consensus estimate of $1.3 billion.

The company also has entered into a definitive agreement to acquire Rural/Metro Corporation (Rural/Metro) through its medical transportation segment American Medical Response (AMR). This pending acquisition enhances Envisions mobile integrated healthcare delivery capability, a key component of its care coordination model amongst its pre-hospital, acute care and post-acute care services.

Rural/Metro is expected to generate annualized 2015 revenue of approximately $600... More